Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Affymax Jumps Most in 16 Months on FDA Review of Anemia Drug
Affymax Jumps Most in 16 Months on FDA Review of Anemia Drug
Affymax Jumps Most in 16 Months on FDA Review of Anemia Drug
Submitted by
admin
on December 5, 2011 - 1:34pm
Source:
Bloomberg
News Tags:
Affymax
FDA
anemia
chronic kidney disease
JNJ
Amgen
peginesatide
Headline:
Affymax Jumps Most in 16 Months on FDA Review of Anemia Drug
Do Not Allow Advertisers to Use My Personal information
